Researchers found significant sex-based differences in ILD in patients with interdisciplinary indications for complete ...

The first comprehensive analysis of three lung diseases across the England, Wales, Scotland, and Northern Ireland has been ...

This is part two of a two-part Healio Exclusive series on nutrition and lung health. Part one can be viewed here. Diet is an ...

Leading specialists in pulmonology have formed Healio Pulmonology’s Peer Perspective Board to help guide coverage and provide ...

Insmed invests heavily in a robust pipeline with multi-billion potential, positioning for future growth. Check out why INSM ...

AstraZeneca and Daiichi Sankyo are aiming to establish their star antibody-drug conjugate (ADC) Enhertu as a first-line ...

Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the ...

DESTINY-Breast09 phase 3 trial of Daiichi Sankyo and AstraZeneca’s ENHERTU is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2 positive metastatic ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...